Screener
Taysha Gene Therapies, Inc. TSHA Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-207666
FAQ
- What is Taysha Gene Therapies, Inc.'s net margin?
- Taysha Gene Therapies, Inc. (TSHA) reported net margin of -1,738.4% in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s net margin changed year-over-year?
- Taysha Gene Therapies, Inc.'s net margin decreased by 44.7% year-over-year, from -1,201.1% to -1,738.4%.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s net margin?
- Over 2 years (2022 to 2025), Taysha Gene Therapies, Inc.'s net margin has grown at a -59.0% compound annual growth rate (CAGR), from -6,635.3% to -1,115.3%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Taysha Gene Therapies, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude